Task: Answer the multiple-choice question.
Question: Which drug exhibits a -0.738% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1cc(C)c(NC(=O)NC(=O)c2ccc(F)cc2)c(C)n1
b.) COCCNC(=O)/C(C#N)=C/c1ccc(N2CCOCC2)o1
Answer: a. Cc1cc(C)c(NC(=O)NC(=O)c2ccc(F)cc2)c(C)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)c(NC(=O)NC(=O)c2ccc(F)cc2)c(C)n1
Cc1cc(C)c(NC(=O)NC(=O)c2ccc(F)cc2)c(C)n1
4-fluoro-N-[(2,4,6-trimethylpyridin-3-yl)carbamoyl]benzamide